Somerset Trust »

Tg Therapeutics shares owned by Somerset Trust

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Somerset Trust from 13F filings

Historical chart of Somerset Trust investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Somerset Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Somerset Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $152k 10k 15.21
2023-12-31 $171k 10k 17.08
2023-09-30 $84k 10k 8.36

More positions owned by Somerset Trust

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Jpmorgan Chase & Co Common Stock (JPM)
Lowes Cos Common Stock (LOW)
Johnson And Johnson Common Stock (JNJ)
Amgen Common Stock (AMGN)
Nextera Energy Common Stock (NEE)
Cisco Sys Common Stock (CSCO)
Linde Int'l Common Stock (LIN)
Analog Devices Common Stock (ADI)
Illinois Tool Works Common Stock (ITW)
First Tr Exchange Traded Fd Dj Internt Idx Exchange Traded Fund (FDN)
Aflac Common Stock (AFL)
Mcdonalds Corp Common Stock (MCD)
Costco Whsl Corp Common Stock (COST)

View all positions for Somerset Trust

Top funds holding Tg Therapeutics

Vanguard Group
Darwin Global Management
Millennium Management
Wellington Management Company
Opaleye Management
Paradigm Biocapital Advisors
683 Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management
Norges Bank Investment Management
Marshall Wace
Gts Securities
Soleus Capital Management
Jane Street

View all funds holding Tg Therapeutics